Literature DB >> 33659379

Assessing Gαq/15-signaling with IP-One: Single Plate Transfection and Assay Protocol for Cell-Based High-Throughput Assay.

Élie Besserer-Offroy1, Rebecca L Brouillette2,3,4, Jean-Michel Longpré2,3,4, Philippe Sarret2,3,4.   

Abstract

Cell-based functional assays are an important part of compound screening and drug lead optimization, and they can also play a crucial role in the determination of the residues involved in ligand binding and signaling for a particular G-protein-coupled receptor. Conventional methods used for Gαq/15-coupled receptors rely on the use of fluorescent probes for Ca++ sensing (such as Fura-2 and Fluo-4) or on the incorporation of [3H]-inositol into inositol 1,4,5- triphosphate (IP3). However, these methods are not suitable for screening large libraries of compounds or for screening several mutants of the same receptor. In contrast, the IP-One assay by Cisbio is a TR-FRET assay suitable for large compound library screening when using stable cell lines that express a specific 7TMR. However, when using transiently transfected mutants of a 7TMR, this assay is not ideal, as it requires a two-step protocol of cell culture. Therefore, we have optimized the IP-One assay protocol using the reverse transfection method in 384-well plates. This offers a time- and resource-efficient alternative to the two-step protocol previously used for the screening of several mutants of Gαq/15-coupled 7TMRs.
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Gα15/16 signaling Inositol phosphate ; Gαq signaling ; G-protein-coupled receptor; IP-One; Seven-transmembrane receptor; Signal transduction.

Year:  2020        PMID: 33659379      PMCID: PMC7842692          DOI: 10.21769/BioProtoc.3715

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  11 in total

1.  Characterization of CHO cells stably expressing a G alpha 16/z chimera for high throughput screening of GPCRs.

Authors:  David C New; Yung H Wong
Journal:  Assay Drug Dev Technol       Date:  2004-06       Impact factor: 1.738

2.  Identification of orphan G protein-coupled receptor ligands using FLIPR assays.

Authors:  Nicola M Robas; Mark D Fidock
Journal:  Methods Mol Biol       Date:  2005

Review 3.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

4.  Angiotensin II cyclic analogs as tools to investigate AT1R biased signaling mechanisms.

Authors:  David St-Pierre; Jérôme Cabana; Brian J Holleran; Élie Besserer-Offroy; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne; Richard Leduc
Journal:  Biochem Pharmacol       Date:  2018-04-20       Impact factor: 5.858

5.  Comparison on functional assays for Gq-coupled GPCRs by measuring inositol monophospate-1 and intracellular calcium in 1536-well plate format.

Authors:  Ke Liu; Steve Titus; Noel Southall; Pingjun Zhu; James Inglese; Christopher P Austin; Wei Zheng
Journal:  Curr Chem Genomics       Date:  2008-07-11

6.  Identifying nonselective hits from a homogeneous calcium assay screen.

Authors:  Kelly J Cassutt; Michael J Orsini; Mojgan Abousleiman; Dean Colone; Weimin Tang
Journal:  J Biomol Screen       Date:  2007-02-08

7.  Development of an improved IP(1) assay for the characterization of 5-HT(2C) receptor ligands.

Authors:  Jean Y Zhang; Dianne M Kowal; Stanley P Nawoschik; John Dunlop; Mark H Pausch; Ravikumar Peri
Journal:  Assay Drug Dev Technol       Date:  2010-02       Impact factor: 1.738

8.  Novel Agonist Bioisosteres and Common Structure-Activity Relationships for The Orphan G Protein-Coupled Receptor GPR139.

Authors:  Mohamed A Shehata; Anne C Nøhr; Delphine Lissa; Christoph Bisig; Vignir Isberg; Kirsten B Andersen; Kasper Harpsøe; Fredrik Björkling; Hans Bräuner-Osborne; David E Gloriam
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

9.  Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors.

Authors:  Anastasiia Gusach; Aleksandra Luginina; Egor Marin; Rebecca L Brouillette; Élie Besserer-Offroy; Jean-Michel Longpré; Andrii Ishchenko; Petr Popov; Nilkanth Patel; Taku Fujimoto; Toru Maruyama; Benjamin Stauch; Margarita Ergasheva; Daria Romanovskaia; Anastasiia Stepko; Kirill Kovalev; Mikhail Shevtsov; Valentin Gordeliy; Gye Won Han; Vsevolod Katritch; Valentin Borshchevskiy; Philippe Sarret; Alexey Mishin; Vadim Cherezov
Journal:  Nat Commun       Date:  2019-12-06       Impact factor: 14.919

10.  Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs.

Authors:  Aleksandra Luginina; Anastasiia Gusach; Egor Marin; Alexey Mishin; Rebecca Brouillette; Petr Popov; Anna Shiriaeva; Élie Besserer-Offroy; Jean-Michel Longpré; Elizaveta Lyapina; Andrii Ishchenko; Nilkanth Patel; Vitaly Polovinkin; Nadezhda Safronova; Andrey Bogorodskiy; Evelina Edelweiss; Hao Hu; Uwe Weierstall; Wei Liu; Alexander Batyuk; Valentin Gordeliy; Gye Won Han; Philippe Sarret; Vsevolod Katritch; Valentin Borshchevskiy; Vadim Cherezov
Journal:  Sci Adv       Date:  2019-10-09       Impact factor: 14.136

View more
  1 in total

1.  Structural insights on ligand recognition at the human leukotriene B4 receptor 1.

Authors:  Nairie Michaelian; Anastasiia Sadybekov; Élie Besserer-Offroy; Gye Won Han; Harini Krishnamurthy; Beata A Zamlynny; Xavier Fradera; Phieng Siliphaivanh; Jeremy Presland; Kerrie B Spencer; Stephen M Soisson; Petr Popov; Philippe Sarret; Vsevolod Katritch; Vadim Cherezov
Journal:  Nat Commun       Date:  2021-05-20       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.